Oslo Børs
Stockholmsbörsen
Københavns Fondsbørs
Investeringsforeninger
Helsingin pörssi
World Indices
US Stocks
US 30
Nasdaq 100
US 500
Toronto Stock Exchange
London Stock Exchange
Euronext Amsterdam
Euronext Brussel
DAX
SDAX
TECDAX
CDAX
MDAX
Prime Standard
CAC 40
Mumbai S.E.
National S.E.
Commodities
Currency
Cryptocurrency
Exchange Traded Funds
Investtech Indices
Viracta Therapeutics (VIRX.US)
Close: 0.20 (0.00), Oct 31, 2024
See Recommendation
Automatic technical analysis. Medium term, Oct 31, 2024
Viracta Therapeutics is in a falling trend channel in the medium long term. This shows that investors over time have sold at lower prices to get out of the stock, and indicates negative development for the company. The stock has broken a support level in the short term and given a negative signal for the short term trading range. The stock has broken down through support at dollar 0.22. This predicts a further decline. In case of positive reactions, there will now be resistance at dollar 0.22.Recommendation one to six months: See Recommendation
Learn more about key technical aspects of this stock:
Support and resistanceBreak downward through support
A break downward through support is a sell signal. Especially if volume is also increasing. The buyers who used to be at this level are gone, but there is still sales pressure in the stock.
TrendFalling trend
Falling trends indicate that the company experiences negative development and decreasing buy interest among investors.
Partners
Investtech in the media
Digital Investor
Dagbladet
Hegnar
E24
Placera
How Investtech works
Collect stock market data
Price, volume, insider information, corporate actions etc.
Perform advanced analysis
Using mathematical pattern recognition, statistical optimization and behavioural finance
Deliver actionable insights
Daily across the stocks, indices and commodities that matter most to your portfolio
Investtech by the numbers
Experience
26years
since 1997
Model portfolio
14.5%
average annual return
Analysis across
20+
stock exchanges
Recommendations of
30 000+
stocks, indices, currencies, cryptocurrencies and commodities
Pricing
Investor
Everything you need to start planning your investment decisions.
€
19
€
12
/ month
Billed Annually: € 149
Order- Analysis of stocks listed at Nasdaq, NYSE, AMEX Stock Exchanges
- Medium and long term charts ⓘAnalyses for the medium and long term, respectively 1-6 months and 1-6 quarters investment perspective.
Medium and long term charts → - Concrete buy and sell signals ⓘSpecific buy and sell signals for each stock.
- Health Check ⓘGet a detailed portfolio health check.
- Today's Case ⓘToday's Case gives you a selected stock which is technically positive.
- Top 50 ⓘThe Top50 list provides you with a ranking of the 50 most positive/negative stocks.
Top 50 → - Price alerts ⓘYou may enter a price alert for a stock and be notified when the price reaches this level.
Price alerts →
Most Popular
Trader
Take your investment decisions to another level with short term analyses and more advanced tools.
€
49
€
29
/ month
Billed Annually: € 349
Order- All Investor features
- +
- Short term charts and analyses ⓘAnalyses for the short term, 1-6 weeks investment perspective.
Short term charts and analyses → - Morning reports ⓘThe report consists of daily evaluations by Investtech`s automated analysis system.
- Trend signals ⓘThe Trend signals tool shows stocks that recently entered into a rising or falling trend.
Trend signals → - Pivot points ⓘPivot points are tops and bottoms in the chart.
Pivot points → - Candlesticks ⓘCandlestick analysis is the best tool for doing a detailed short term volume analysis.
Candlesticks →
Professional
A wide range of advanced selection tools and overall analysis to scale your investments.
€
119
€
74
/ month
Billed Annually: € 899
Order- All Trader features
- +
- Overall analysis ⓘOverall analysis for all time perspectives; long, medium and short term.
Overall analysis → - Stock selection ⓘStock selection is likely the best stock picking tool Investtech offers. The most common usage is to select liquidity and time perspective, e.g. 50 % most liquid and short term.
Stock selection → - Hausse ⓘThe Hausse indices are indicators of optimism.
Hausse → - Compare stocks ⓘCompare the price development of a stock with 30,000 other stocks, commodities and indices.
Compare stocks → - Trading opportunities ⓘThe Trading opportunities table is a stock picking tool. The table shows stocks with combinations of technical indicators that strongly indicate further rise or fall.
Trading opportunities → - Seasonal variations ⓘAnalysis of seasonal variations shows how a stock statistically has varied throughout the year.
Seasonal variations → - Ranking by signals ⓘAn overview of the latest buy and sell signals identified by Investtech`s systems. Signals from price patterns are assumed to indicate in which direction the majority of investors are moving.
Ranking by signals →
Institutional
Access to all 30,000 stocks, commodities and currencies, suited for experienced investment strategists.
Get in touch
Contact us - All Professional features
- +
- All 30,000 stocks, commodities and currencies ⓘAll 30,000 stocks, commodities and currencies.
- Self-defined universes ⓘDefine your own universe of stocks.
- Alarms ⓘOverview of the stocks in your universes that have triggered signals.
- Personal customer service representative for technical questions ⓘContact your personal customer service representative with any technical questions you may have.
- Flexible selection criteria ⓘWide range of flexible selection criteria.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Head office
Strandveien 171366 Lysaker, Norway
Research department
Instituttveien 102007 Kjeller, Norway
+47 21 555 888
Contact us
×
